Limited and External Funding Opportunities

Contact us...

  • Email if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.


Have you been awarded a Limited Submission recognition?

Please let us know at

Research Awards Banner.png

Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees

Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.


  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to


  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

NSF Louis Stokes Community Resource Centers (LSCRCs)

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to

Applications due April 3, 2023

VUMC may submit one application to the June 2023 cycle of the NSF LSAMP National Coordination Hub and Louis Stokes Community Resource Centers program.

**For this cycle, NSF is only accepting applications for Louis Stokes Community Resource Centers. Applications for the LSAMP National Coordination Hub are not being accepted.**

This solicitation from the Louis Stokes Alliances for Minority Participation (LSAMP) calls for proposals for Louis Stokes Community Resource Centers (LSCRCs). This new funding opportunity will support the overall goal of the LSAMP program to assist universities and colleges in diversifying the nation's science, technology, engineering, and mathematics (STEM) workforce by increasing the number of STEM baccalaureate and graduate degrees awarded to individuals from populations underrepresented in these disciplines: Blacks and African Americans, Alaska Natives, American Indians, Hispanic and Latino Americans, Native Hawaiians, and Native Pacific Islanders.


Proposals for a LSCRC may be submitted by any consortium of organizations. All active alliances are eligible to submit as lead organizations. LSAMP organizations, non-LSAMP organizations and other organizational types with expertise in STEM education research and broadening participation in STEM fields are eligible to submit as lead organizations. Non-LSAMP organizations should have knowledge of and prior engagement with the LSAMP community as evidenced by development of and participation in LSAMP activities over time. Minority-serving institutions (Historically Black Colleges and Universities, Hispanic-serving colleges and universities, Tribal colleges and universities) and non-academic organizations are encouraged to submit as lead participants.

Louis Stokes Community Resource Center

The LSCRCs will accelerate the pace of knowledge generation and research dissemination in the areas of broadening participation, STEM education for LSAMP populations, and preparation for national STEM priorities. In addition, the LSCRCs will support a community of researchers and facilitate scholarly opportunities that will further advance the overall goal of the LSAMP program to diversify the nation's STEM workforce.

LSCRCs are three- to five-year projects that have wide latitude for design of research, outreach, and synthesis activities. The maximum funding level is $700,000 per year. LSCRC awards will be Continuing Grants.

Applicants are encouraged to build partnerships with at least one of these entities, i.e. research organization, Science & Technology (S&T) center, national laboratory, industry, private foundation, or professional STEM society/organization that can contribute to evidence-based results in STEM education. Ideally, the partnership should consist of majority-and minority-serving institutions, including community colleges. Consortia of LSAMP-funded community colleges with demonstrated evidence of successful transfer of students to four-year STEM degree programs are encouraged to apply for LSCRC funding.

The activities of the Hub, along with the new LSCRCs, will complement and amplify the work of the existing alliances and assist in wider dissemination of knowledge production from LSAMP activities. They will also support the program in further development of partnerships both across the LSAMP community and with other national efforts.

See the solicitation for more details.

Internal Application Process

Anyone interested in being considered to submit one of VUMC’s proposals must submit the following (in a single PDF) to by 5 p.m. on April 3, 2023:

  1. Brief (2 page maximum) project description including summary budget
  2. Letter of support from department chair/center director
  3. NIH Biosketch

Any questions about this opportunity may be directed to

2023 Conservation, Food & Health Foundation Grants

Applications due April 10, 2023

VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to

Vanderbilt University may submit one application to the July 2023 cycle of the Conservation, Food and Health Foundation (CFH) Grants program. The CFH seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East. The Foundation supports projects and applied research that:

  • Generate local or regional solutions to problems affecting the quality of the environment and human life;
  • Advance local leadership and promote professional development in the conservation, agricultural, and health sciences;
  • Develop the capacity of local organizations and coalitions; and
  • Address challenges in the field.

The Foundation prefers to support projects that address under-funded issues and geographic areas.

The Foundation funds applied research, pilot projects, new initiatives, training, and technical assistance, rather than ongoing support for programs that are already well underway. An important goal for the Foundation is to provide seed money to help promising projects, organizations, and individuals develop the track record they need to attract major foundation funding in the future.

There is no minimum or maximum grant size. It is anticipated that most grants will fall in the $25,000-$50,000 per year range. Awards do not support indirect costs.

Grants are made for a one- or two-year period. Second-year funding is conditional on the provision of a satisfactory progress report, interim financial report, and work plan.

Health Projects:

The Foundation supports efforts that test new ideas and approaches that promote public health, with a special emphasis on reproductive health and family planning and their integration with other health promotion activities. It favors community-level disease prevention and health promotion projects and efforts that help strengthen regional and country public health systems over disease diagnosis, treatment, and care provided by clinics, hospitals, and humanitarian aid programs.

Activities that help increase capacity include applied research, program development, technical assistance, and training projects that:

  • Promote reproductive health and family planning.
  • Address issues related to mental and behavioral health.
  • Address issues relating to pollution and environmental health.
  • Increase the understanding of zoonotic and neglected tropical diseases.
  • Address issues relating to nutrition and health.

See the guidelines and previous grantees for more information.

Internal Application Process

Anyone interested in being considered as VUMC’s nominee must submit the following (in a single PDF) to by April 10, 2023.

  1. Brief (2 page maximum) research plan including summary budget
  2. Statement of support from department chair/center director
    1. Letter must acknowledge that this grant does not allow indirect costs. This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. NIH Biosketch or 5-page CV

Any questions about this opportunity may be directed to

2023 Incyte Ingenuity Awards in Graft-Versus-Host-Disease

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to

Applications due April 11, 2023

VUMC may submit up to 5 applications to the 2023 Incyte Ingenuity Awards in graft-versus-host-disease (GVHD).

GVHD is a life-threatening condition that occurs when donor immune cells attack the recipient’s organs and tissues after an allogeneic stem cell transplant. Incyte is deeply dedicated to improving the lives of patients with serious diseases, including GVHD. As part of this commitment, the company has announced the Incyte Ingenuity Awards in GVHD to continue to foster collaboration amongst key stakeholders to address the specific needs of the GVHD community.

These awards aim to support the GVHD community by funding two novel initiatives that address challenges faced by GVHD patients, caregivers, and healthcare providers. Incyte is currently offering two, one-year awards, one for an initiative up to $35,000 and another for an initiative up to $100,000. Programs cannot include indirect costs in the proposed budget.

When applying for this award, Incyte encourages eligible applicants to partner with and collaborate with patient groups, professional societies, and patient advocates within the community.


  • Programs must be independent of any ongoing activities, with the exception of considerably expanding an existing program.
  • Healthcare providers and mid-level/junior faculty of healthcare organizations are eligible to submit. However, applications must be submitted in the name of an institution, not on behalf of an individual.

Applications will be disqualified if:

  • Focus is on a particular therapeutic agent, translational research, or clinical research that is interventional in nature.
  • Defined scope does not serve or plan to address a specific need of the GVHD community.

See the program website and FAQs for more details.

Internal Application Process

Anyone interested in being considered to submit one of VUMC’s proposals must submit the following (in a single PDF) to by 5 p.m. on April 11, 2023:

  1. Brief (2 page maximum) project description including summary budget
    1. Project description should include objectives and summary of how the project addresses a specific need for the GVHD community; Identify any collaboration and connection to the GVHD community, if applicable.
  2. Letter of support from department chair/center director
    1. Letter must acknowledge that this award does not allow indirect costs. ** This statement can be used/modified within the letter: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional/school policy.”
  3. NIH Biosketch

Any questions about this opportunity may be directed to


Research Awards Banner.png

Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact for more information.

HHMI Investigator Program

Applications due March 21

The Howard Hughes Medical Institute (HHMI) is seeking creative and innovative scientists to join its Investigator Program. HHMI Investigators are basic researchers and physician scientists across the nation who catalyze discovery research in basic and biomedical sciences, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology. Approximately 25 new Investigators will be selected. 

HHMI seeks values the perspectives of people with different backgrounds and experiences and seeks a diverse applicant pool. They have developed new resources for applicants, including an instructional video and sample applications.

Applications are due by March 21, 2023. For additional information please visit the HHMI website. 

The Investigator Program is open to individuals who:
1.    hold a PhD and/or MD (or the equivalent).
2.    have a tenured or tenure-track position as an assistant professor or higher academic rank (or the equivalent)
3.    have more than 5, but no more than 15, years of post-training, professional experience. To meet this requirement, the applicant’s first post-training professional appointment must have begun no earlier than March 1, 2008, and no later than April 1, 2018.
4.    are the principal investigator on one or more active, national, peer-reviewed research grants with an initial duration of at least three years as of April 1, 2023. (Mentored awards and training grants do not qualify. Multi-investigator grants may qualify.)
5.    have an ORCID iD
6.    Other important conditions include devoting at least 75% of professional activities to the direct conduct of research. See full list of considerations on the HHMI site:…;

National Center for Medical Rehabilitation Research (NCMRR) Early Career Research Award (R03 Clinical Trial Optional)

Applications due March 28

The NCMRR Early Career Research (ECR) Award is different from other NIH R03 programs, including the Parent R03 Announcement. It is restricted to clinical and basic scientists who are in the early stages of their independent career in rehabilitation research. For projects supported by a ECR R03 Award, successful results should provide a solid foundation for further research under the R01 funding mechanism.

Given that the goal is to collect preliminary data, R03 projects may be less immediately impactful or significant compared to the typical R01 or other NIH-funded projects. It is not an expectation that this R03 project will likely "move the field forward" at this stage.

The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices.

The following topics are non-responsive and will be withdrawn prior to review:

  • Projects focusing on cognitive rehabilitation without a physical rehabilitation component
  • Sports medicine rehabilitation for people without physical disabilities (i.e. Projects targeting indications for sports or athletic performance by able-bodied athletes; treatment, recovery and prevention of injuries related to sports and exercise by people without physical disabilities.) 

The proposed project may be technology design-directed, discovery-driven, or hypothesis-driven with the goal of collecting the necessary preliminary data sufficient to apply for an R01 grant. The project may aid in the formulation of hypotheses and may be milestone-driven or descriptive in scope. Preliminary data are not required or expected. However, if available, preliminary data are allowed.

The total budget (direct costs) is up to $200,000 spread over two years. No more than $100,000 in direct costs may be requested in any single year.

HESI THRIVE - Making Cancer Patient Quality of Life an Active Research Priority

Letters of intent due April 10

THRIVE, a 2018 proud partner of the Biden Cancer Initiative, provides seed grants for clinical and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. THRIVE also supports the development of approaches to avoid or lessen these effects. 

THRIVE is interested in research that will advance our:
•    Fundamental understanding of cancer drug or therapy-related toxicity
•    Ability to identify and translate critical biomarkers of toxicity
•    Models (in vitro, in vivo, in silico) of pediatric or adult drug exposure that predict early or impending toxicities 
•    Understanding the role of protective co-therapies or modified exposure protocols on the onset of therapy-induced damage; and
•    Identification of novel protective therapies or dosing strategies.

•    PI's must hold an MD, PhD, DVM or equivalent degree. Candidates for these degrees along with their PI may apply.
•    Candidates must have the ability to conduct independent research and have published in peer-reviewed journals.
•    Range of $20,000 - $50,000 for up to 24 months 
•    Upon agreement to THRIVE award terms, THRIVE will disburse 75% of funds with the remaining provided upon completion of the study milestones.

•    All letters of intent and grant applications are to be submitted through the Proposal Central website here
•    If you are a new user to ProposalCentral, follow the Need an account? link and complete the registration process.   
•    The proposed study's scientific merit, innovation, and ability to translate pre-clinical to clinical research (or vice versa) is key to being selected for funding. 
•    Preference given to studies in which both a non-clinical and a clinical researcher are engaged in either the design, conduct, or analysis of the study results. Click here for Grant Guidelines
•    A total of 3 - 4 grants will be awarded in 2023.

Robert A. Winn Diversity in Clinical Trials: Career Development Award

Applications due May 12

Overview: Part of the Robert A. Winn Diversity in Clinical Trials Award Program, the Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA) is a 2-year program designed to support the career development of early-stage investigator physicians (as defined by NIH) who are underrepresented in medicine (URM) or who have a demonstrated commitment to increasing diversity in clinical research. The program prepares participants to become independent clinical trial investigators engaged in advancing health equity through their research and mentoring.

Description: The Winn CDA offers a comprehensive and integrated approach to increasing diversity in clinical trials through workforce development and clinical trial site development in underserved communities where underrepresented patients receive care. Additionally, the program will assist program investigators in building capacity of clinical trials sites in communities with diverse and heavily burdened patient populations.

Objectives: (1) To transform the clinical research landscape by providing training and resources to build a network of new clinical investigators with both community engagement and research skills. (2) To enhance the capacity of clinical trial sites that serve communities with diverse patient populations.

Award Details: $120K/year for 2 years; require at least 40% of Scholar’s time (Note: Awards will be made to organizations, not to individuals.) It is expected that the award will cover a percentage of the Scholar’s salary to garner 40% of their time. Additionally, funds can be used toward a portion of a research assistant/coordinator salary.

Clinical research focus areas: Oncology, Hematology-Oncology, Cardiovascular Disease, and Immunologic Disorders

Candidate profile: 

  • Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD
  • Eligible candidates will be Early Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies—whichever date is later—within the past 10 years and have not yet competed successfully for a substantial, competing NIH research grant. (Applicants with RO1 or RO1 equivalent are ineligible.)
  • In determining eligible candidates for the Winn CDA program, the following racial/ethnic groups are designated as “underrepresented in medicine”:
    • African American or Black
    • Hispanic or Latine
    • American Indian or Alaska Native
    • Native Hawaiian or Other Pacific Islander
    • Southeast Asian (please specify)
    • OR have a demonstrated commitment to increasing diverse patient participation in clinical trials